NLRP3 and relapsing-remitting multiple sclerosis: These findings comply with the neuroinflammatory roles of SNHG1 and lincRNA-Cox2 in other neurodegenerative diseases and imply that the impact of both lncRNAs on RRMS pathogenesis and disease activity might be mediated, at least partially, via targeting NLRP3 inflammasome activation.